T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
OR Royalties Inc.
OR
$6.59B
| $86.1M | 0.01% |
3,349,511
-266,690
| -7% | -$6.86M |
|
602
Stride
LRN
$7.17B
| $85.8M | 0.01% |
590,945
-68,977
| -10% | -$10M |
|
603
Texas Roadhouse
TXRH
$11.1B
| $85.8M | 0.01% |
457,769
-20,384
| -4% | -$3.82M |
|
604
Light & Wonder
LNW
$7.39B
| $85.7M | 0.01% |
890,696
-11,082
| -1% | -$1.07M |
|
605
HF Sinclair
DINO
$9.56B
| $85.2M | 0.01% |
2,074,509
+379,591
| +22% | +$15.6M |
|
|
CRWV
606
CoreWeave, Inc. Class A Common Stock
CRWV
$49B
| $84.8M | 0.01% |
+519,990
| New | +$84.8M |
|
607
Rhythm Pharmaceuticals
RYTM
$6.63B
| $84.8M | 0.01% |
1,341,392
+142,339
| +12% | +$8.99M |
|
608
Lantheus
LNTH
$3.65B
| $84.6M | 0.01% |
1,033,377
+29,623
| +3% | +$2.42M |
|
609
On Holding
ONON
$14.5B
| $83.8M | 0.01% |
1,609,794
+25,456
| +2% | +$1.33M |
|
610
Summit Therapeutics
SMMT
$14B
| $83.1M | 0.01% |
3,905,148
-2,652,656
| -40% | -$56.4M |
|
611
Jabil
JBL
$22.4B
| $82.6M | 0.01% |
378,504
+164,622
| +77% | +$35.9M |
|
612
Watts Water Technologies
WTS
$9.47B
| $82.5M | 0.01% |
335,658
+3,787
| +1% | +$931K |
|
613
EXL Service
EXLS
$7.14B
| $81.6M | 0.01% |
1,864,176
+123,020
| +7% | +$5.39M |
|
614
Louisiana-Pacific
LPX
$6.91B
| $81.4M | 0.01% |
946,142
-569,195
| -38% | -$48.9M |
|
615
American Electric Power
AEP
$57.5B
| $80.8M | 0.01% |
778,293
+3,733
| +0.5% | +$387K |
|
616
Disc Medicine
IRON
$2.15B
| $80.3M | 0.01% |
1,515,625
+157,371
| +12% | +$8.33M |
|
617
Copart
CPRT
$46.5B
| $80M | 0.01% |
1,630,798
-6,677,484
| -80% | -$328M |
|
618
Brown & Brown
BRO
$30.8B
| $78.4M | 0.01% |
706,967
+30,128
| +4% | +$3.34M |
|
619
Valmont Industries
VMI
$7.49B
| $78.1M | 0.01% |
239,153
+66,186
| +38% | +$21.6M |
|
620
Celldex Therapeutics
CLDX
$1.55B
| $77.7M | 0.01% |
3,817,820
+407,321
| +12% | +$8.29M |
|
|
CNTA
621
Centessa Pharmaceuticals
CNTA
$2.42B
| $77.6M | 0.01% |
5,907,992
+565,648
| +11% | +$7.43M |
|
622
Federal Signal
FSS
$7.59B
| $77.5M | 0.01% |
728,030
+9,816
| +1% | +$1.04M |
|
623
Atmus Filtration Technologies
ATMU
$3.79B
| $76.8M | 0.01% |
2,108,228
-15,149
| -0.7% | -$552K |
|
624
PACCAR
PCAR
$51.6B
| $76.7M | 0.01% |
806,955
+3,422
| +0.4% | +$325K |
|
625
Lamar Advertising Co
LAMR
$12.9B
| $76.5M | 0.01% |
629,946
+92,318
| +17% | +$11.2M |
|